ONTOLOGY REPORT - ANNOTATIONS
| Term: | dimethylarsinic acid |
|
| Accession: | CHEBI:48765
|
browse the term
|
| Definition: | The organoarsenic compound that is arsenic acid substituted on the central arsenic atom with two methyl groups. |
| Synonyms: | related_synonym: | C2H7AsO2; CACODYLIC ACID; C[As](C)(O)=O; InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5); InChIKey=OGGXGZAMXPVRFZ-UHFFFAOYSA-N; Kakodylsaeure; Me2As(=O)OH; [As(CH3)2O(OH)] |
| | alt_id: | CHEBI:29839; CHEBI:48764 |
| | xref_casrn: | 75-60-5 |
| | xref: | ChEMBL:793994 "ChEMBL COMPOUND"; ChemIDplus:1736965 "Beilstein Registry Number"; ChemIDplus:75-60-5 "CAS Registry Number"; CiteXplore:11379771 "PubMed citation"; CiteXplore:21342701 "PubMed citation"; CiteXplore:21457993 "PubMed citation"; CiteXplore:21608259 "PubMed citation"; Gmelin:130562 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D002101 |
| | xref: | NIST Chemistry WebBook:75-60-5 "CAS Registry Number"; PDBeChem:CAD "PDBeChem"; Wikipedia:Cacodylic_acid "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:16223 |
|
|
dimethylarsinic acid
|
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
increases expression |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
5 |
137,729,505 |
137,735,691 |
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
increases expression |
ISO |
12 |
81,268,529 |
81,361,358 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha fetoprotein |
|
increases expression |
EXP |
5 |
90,919,740 |
90,937,933 |
RGD:6480464 |
CTD |
| G |
Agtrap |
angiotensin II, type I receptor-associated protein |
|
decreases expression |
EXP |
4 |
147,451,170 |
147,462,173 |
RGD:6480464 |
CTD |
| G |
Aoc3 |
amine oxidase, copper containing 3 |
|
increases expression |
EXP |
11 |
101,191,920 |
101,200,744 |
RGD:6480464 |
CTD |
| G |
Aoc3 |
amine oxidase, copper containing 3 |
|
multiple interactions |
EXP |
11 |
101,191,920 |
101,200,744 |
RGD:6480464 |
CTD |
| G |
Apol7c |
apolipoprotein L 7c |
|
increases expression |
EXP |
15 |
77,355,297 |
77,363,745 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
16 |
84,954,688 |
85,173,948 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases expression |
EXP |
16 |
84,954,688 |
85,173,948 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
increases expression |
ISO |
4 |
40,980,107 |
40,995,169 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
increases expression |
ISO |
12 |
70,473,137 |
70,476,967 |
RGD:6480464 |
CTD |
| G |
Arhgap21 |
Rho GTPase activating protein 21 |
|
increases expression |
ISO |
2 |
20,769,546 |
20,889,348 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions |
ISO |
19 |
46,781,933 |
46,815,585 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
increases expression |
ISO |
15 |
80,085,614 |
80,087,971 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
increases expression |
ISO |
15 |
80,085,614 |
80,087,971 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
decreases expression |
ISO |
7 |
135,047,587 |
135,053,178 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
decreases expression |
ISO |
14 |
70,874,362 |
70,920,067 |
RGD:6480464 |
CTD |
| G |
Bmpr1a |
bone morphogenetic protein receptor, type 1A |
|
increases expression |
ISO |
14 |
35,224,254 |
35,315,732 |
RGD:6480464 |
CTD |
| G |
Bok |
BCL2-related ovarian killer protein |
|
increases expression |
ISO |
1 |
95,582,271 |
95,592,339 |
RGD:6480464 |
CTD |
| G |
C730007P19Rik |
RIKEN cDNA C730007P19 gene |
|
increases expression |
EXP |
7 |
14,318,854 |
14,364,985 |
RGD:6480464 |
CTD |
| G |
Calm2 |
calmodulin 2 |
|
increases expression |
ISO |
17 |
87,832,741 |
87,846,275 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
ISO |
6 |
29,298,119 |
29,326,675 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
ISO |
6 |
29,298,119 |
29,326,675 |
RGD:6480464 |
CTD |
| G |
Cap1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
|
increases expression |
ISO |
4 |
122,536,471 |
122,563,124 |
RGD:6480464 |
CTD |
| G |
Capn9 |
calpain 9 |
|
increases expression |
ISO |
8 |
127,100,011 |
127,142,631 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
increases expression |
ISO |
9 |
66,561,493 |
66,614,652 |
RGD:6480464 |
CTD |
| G |
Car13 |
carbonic anhydrase 13 |
|
increases expression |
EXP |
3 |
14,641,727 |
14,663,002 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
3 |
14,863,538 |
14,872,381 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
increases expression |
EXP |
9 |
5,345,476 |
5,373,034 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases response to substance |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases response to substance |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases response to substance |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cav2 |
caveolin 2 |
|
decreases expression |
ISO |
6 |
17,231,341 |
17,239,011 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
increases expression |
EXP |
4 |
21,654,850 |
21,677,693 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
multiple interactions |
EXP |
4 |
21,654,850 |
21,677,693 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
affects expression |
ISO |
6 |
127,075,726 |
127,101,066 |
RGD:6480464 |
CTD |
| G |
Cd2 |
CD2 antigen |
|
increases expression |
ISO |
3 |
101,079,831 |
101,091,862 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
decreases expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd68 |
CD68 antigen |
|
increases expression |
ISO |
11 |
69,477,873 |
69,479,564 |
RGD:6480464 |
CTD |
| G |
Cdc123 |
cell division cycle 123 |
|
increases expression |
ISO |
2 |
5,715,340 |
5,766,006 |
RGD:6480464 |
CTD |
| G |
Cdc37 |
cell division cycle 37 |
|
increases expression |
ISO |
9 |
20,942,985 |
20,954,350 |
RGD:6480464 |
CTD |
| G |
Cdc5l |
cell division cycle 5-like (S. pombe) |
|
increases expression |
ISO |
17 |
45,528,836 |
45,570,656 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
affects expression |
ISO |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdh4 |
cadherin 4 |
|
increases expression |
EXP |
2 |
179,177,183 |
179,634,080 |
RGD:6480464 |
CTD |
| G |
Cdh4 |
cadherin 4 |
|
multiple interactions |
EXP |
2 |
179,177,183 |
179,634,080 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
decreases expression |
ISO |
8 |
101,552,669 |
101,940,357 |
RGD:6480464 |
CTD |
| G |
Cdk9 |
cyclin-dependent kinase 9 (CDC2-related kinase) |
|
increases expression |
ISO |
2 |
32,561,302 |
32,568,304 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
decreases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
decreases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
decreases expression |
ISO |
7 |
35,831,441 |
35,841,585 |
RGD:6480464 |
CTD |
| G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) |
|
decreases expression |
ISO |
9 |
108,728,651 |
108,755,300 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
EXP |
10 |
79,353,598 |
79,355,401 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
multiple interactions |
EXP |
10 |
79,353,598 |
79,355,401 |
RGD:6480464 |
CTD |
| G |
Chat |
choline acetyltransferase |
|
increases activity |
EXP |
14 |
33,221,389 |
33,279,095 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
increases expression |
ISO |
5 |
111,269,036 |
111,303,152 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
decreases expression |
EXP |
9 |
108,855,790 |
108,886,920 |
RGD:6480464 |
CTD |
| G |
Comp |
cartilage oligomeric matrix protein |
|
increases expression |
ISO |
8 |
72,897,447 |
72,905,965 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
decreases expression |
ISO |
11 |
76,590,710 |
76,660,510 |
RGD:6480464 |
CTD |
| G |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
|
increases expression |
EXP |
15 |
30,102,348 |
30,959,099 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
|
multiple interactions |
ISO |
7 |
26,682,683 |
26,711,643 |
RGD:6480464 |
CTD |
| G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
|
increases expression |
ISO |
7 |
26,682,683 |
26,711,643 |
RGD:6480464 |
CTD |
| G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
|
multiple interactions |
ISO |
7 |
26,846,514 |
26,881,215 |
RGD:6480464 |
CTD |
| G |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
|
increases expression |
EXP |
5 |
146,788,770 |
146,821,194 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
3 |
17,971,950 |
18,143,338 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
3 |
17,971,950 |
18,143,338 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
10 |
126,727,849 |
126,733,344 |
RGD:6480464 |
CTD |
| G |
Ddx3y |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked |
|
increases expression |
EXP |
Y |
597,158 |
623,056 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
decreases expression |
ISO |
9 |
78,326,260 |
78,329,531 |
RGD:6480464 |
CTD |
| G |
EG628438 |
predicted gene, EG628438 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Eif2s3y |
eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked |
|
increases expression |
EXP |
Y |
347,055 |
365,037 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
increases expression |
ISO |
13 |
118,009,380 |
118,063,222 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
EXP |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
increases expression |
EXP |
3 |
37,247,575 |
37,303,752 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
decreases expression |
EXP |
6 |
127,022,920 |
127,031,426 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
ISO |
14 |
58,691,523 |
58,731,557 |
RGD:6480464 |
CTD |
| G |
Fibcd1 |
fibrinogen C domain containing 1 |
|
decreases expression |
EXP |
2 |
31,668,810 |
31,701,525 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
decreases expression |
ISO |
X |
160,811,480 |
160,840,579 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
increases expression |
ISO |
13 |
31,650,039 |
31,652,845 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin heavy chain 1 |
|
increases expression |
ISO |
19 |
10,057,193 |
10,059,582 |
RGD:6480464 |
CTD |
| G |
Ftl1 |
ferritin light chain 1 |
|
increases expression |
ISO |
7 |
52,713,314 |
52,715,256 |
RGD:6480464 |
CTD |
| G |
Fut11 |
fucosyltransferase 11 |
|
decreases expression |
EXP |
14 |
21,514,190 |
21,519,419 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gak |
cyclin G associated kinase |
|
increases expression |
ISO |
5 |
108,998,433 |
109,058,758 |
RGD:6480464 |
CTD |
| G |
Gdi2 |
guanosine diphosphate (GDP) dissociation inhibitor 2 |
|
increases expression |
ISO |
13 |
3,537,321 |
3,565,507 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
increases expression |
ISO |
X |
98,572,676 |
98,580,964 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin |
|
increases expression |
ISO |
13 |
75,977,334 |
75,987,599 |
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
increases expression |
ISO |
10 |
127,631,691 |
127,647,060 |
RGD:6480464 |
CTD |
| G |
Gng5 |
guanine nucleotide binding protein (G protein), gamma 5 |
|
increases expression |
EXP |
3 |
146,162,800 |
146,168,507 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases expression |
ISO |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
increases expression |
ISO |
11 |
102,291,636 |
102,298,123 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
increases expression |
ISO |
5 |
36,807,834 |
36,816,726 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
|
decreases expression |
ISO |
9 |
78,178,827 |
78,194,952 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
|
increases expression |
ISO |
9 |
78,178,827 |
78,194,952 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
increases expression |
ISO |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
increases expression |
ISO |
3 |
107,815,168 |
107,820,891 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase, theta 1 |
|
affects response to substance |
ISO |
10 |
75,246,558 |
75,261,329 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase, theta 1 |
|
affects metabolic processing |
ISO |
10 |
75,246,558 |
75,261,329 |
RGD:6480464 |
CTD |
| G |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
|
increases expression |
ISO |
14 |
76,296,744 |
76,410,672 |
RGD:6480464 |
CTD |
| G |
H1f0 |
H1 histone family, member 0 |
|
increases expression |
ISO |
15 |
78,858,642 |
78,860,934 |
RGD:6480464 |
CTD |
| G |
Hapln2 |
hyaluronan and proteoglycan link protein 2 |
|
decreases expression |
ISO |
3 |
87,825,672 |
87,831,433 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeobox A1 |
|
decreases expression |
ISO |
6 |
52,105,366 |
52,108,316 |
RGD:6480464 |
CTD |
| G |
Hoxa2 |
homeobox A2 |
|
decreases expression |
ISO |
6 |
52,112,510 |
52,114,830 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
decreases expression |
EXP |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
multiple interactions |
EXP |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa4l |
heat shock protein 4 like |
|
multiple interactions |
EXP |
3 |
40,549,535 |
40,594,287 |
RGD:6480464 |
CTD |
| G |
Hspa4l |
heat shock protein 4 like |
|
decreases expression |
EXP |
3 |
40,549,535 |
40,594,287 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock protein 8 |
|
decreases expression |
EXP |
9 |
40,609,356 |
40,613,282 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock protein 8 |
|
multiple interactions |
EXP |
9 |
40,609,356 |
40,613,282 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
EXP |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
1 |
55,144,992 |
55,148,161 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
|
decreases expression |
EXP |
5 |
150,419,420 |
150,438,890 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
|
multiple interactions |
EXP |
5 |
150,419,420 |
150,438,890 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
increases expression |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
11 |
7,097,790 |
7,102,549 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
increases expression |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
decreases expression |
ISO |
10 |
126,786,458 |
126,788,828 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
ISO |
11 |
53,583,516 |
53,591,876 |
RGD:6480464 |
CTD |
| G |
Irf5 |
interferon regulatory factor 5 |
|
decreases expression |
ISO |
6 |
29,476,733 |
29,487,319 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
|
decreases expression |
ISO |
8 |
131,209,554 |
131,257,479 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
|
increases expression |
ISO |
8 |
131,209,554 |
131,257,479 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin beta 6 |
|
decreases expression |
ISO |
2 |
60,436,349 |
60,560,660 |
RGD:6480464 |
CTD |
| G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
|
increases expression |
ISO |
14 |
31,721,758 |
31,736,773 |
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
decreases expression |
ISO |
2 |
136,907,194 |
136,942,067 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
decreases expression |
ISO |
19 |
29,326,318 |
29,387,570 |
RGD:6480464 |
CTD |
| G |
Kdm5d |
lysine (K)-specific demethylase 5D |
|
increases expression |
EXP |
Y |
234,231 |
280,254 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
increases expression |
ISO |
4 |
148,550,430 |
148,681,807 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
increases expression |
EXP |
11 |
97,021,024 |
97,049,206 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
multiple interactions |
EXP |
11 |
97,021,024 |
97,049,206 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
decreases expression |
ISO |
15 |
101,858,647 |
101,862,457 |
RGD:6480464 |
CTD |
| G |
Krt25 |
keratin 25 |
|
increases expression |
EXP |
11 |
99,177,158 |
99,184,255 |
RGD:6480464 |
CTD |
| G |
Krtap14 |
keratin associated protein 14 |
|
increases expression |
EXP |
16 |
88,825,536 |
88,826,390 |
RGD:6480464 |
CTD |
| G |
Krtap8-1 |
keratin associated protein 8-1 |
|
increases expression |
EXP |
16 |
89,487,619 |
89,488,197 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactose binding, soluble 3 |
|
increases expression |
ISO |
14 |
47,993,535 |
48,005,842 |
RGD:6480464 |
CTD |
| G |
Lman1 |
lectin, mannose-binding, 1 |
|
increases expression |
ISO |
18 |
66,140,393 |
66,162,289 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
decreases expression |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen-activated protein kinase kinase kinase 12 |
|
decreases expression |
EXP |
15 |
102,328,078 |
102,347,435 |
RGD:6480464 |
CTD |
| G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
|
increases expression |
EXP |
11 |
103,081,078 |
103,128,715 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases expression |
EXP |
10 |
19,654,332 |
19,862,556 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
decreases expression |
EXP |
4 |
132,796,733 |
132,808,843 |
RGD:6480464 |
CTD |
| G |
Map4k1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
|
decreases expression |
ISO |
7 |
29,767,873 |
29,788,298 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases expression |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mas1 |
MAS1 oncogene |
|
decreases expression |
EXP |
17 |
13,033,871 |
13,061,009 |
RGD:6480464 |
CTD |
| G |
Mbtps1 |
membrane-bound transcription factor peptidase, site 1 |
|
increases expression |
ISO |
8 |
122,032,051 |
122,082,661 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
increases expression |
ISO |
10 |
117,125,961 |
117,147,772 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
increases expression |
ISO |
7 |
86,278,654 |
86,293,946 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
ISO |
6 |
138,089,058 |
138,105,273 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
EXP |
9 |
7,272,514 |
7,283,333 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
EXP |
9 |
7,272,514 |
7,283,333 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
increases expression |
EXP |
14 |
55,050,441 |
55,060,095 |
RGD:6480464 |
CTD |
| G |
Mmp17 |
matrix metallopeptidase 17 |
|
increases expression |
EXP |
5 |
130,090,089 |
130,114,086 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
decreases expression |
ISO |
17 |
88,071,897 |
88,123,053 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mta1 |
metastasis associated 1 |
|
increases expression |
ISO |
12 |
114,336,489 |
114,375,417 |
RGD:6480464 |
CTD |
| G |
Nbl1 |
neuroblastoma, suppression of tumorigenicity 1 |
|
increases expression |
ISO |
4 |
138,638,207 |
138,648,885 |
RGD:6480464 |
CTD |
| G |
Neo1 |
neogenin |
|
increases expression |
EXP |
9 |
58,722,486 |
58,884,248 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
increases expression |
ISO |
4 |
97,248,634 |
97,785,567 |
RGD:6480464 |
CTD |
| G |
Nfic |
nuclear factor I/C |
|
increases expression |
ISO |
10 |
80,858,936 |
80,889,918 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
increases expression |
ISO |
X |
132,804,792 |
132,806,517 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
increases expression |
ISO |
13 |
49,282,916 |
49,291,620 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
affects expression |
ISO |
2 |
26,313,422 |
26,359,342 |
RGD:6480464 |
CTD |
| G |
Notch3 |
notch 3 |
|
increases expression |
ISO |
17 |
32,257,838 |
32,303,797 |
RGD:6480464 |
CTD |
| G |
Npy5r |
neuropeptide Y receptor Y5 |
|
decreases expression |
EXP |
8 |
69,203,864 |
69,211,993 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
ISO |
8 |
32,928,500 |
33,028,675 |
RGD:6480464 |
CTD |
| G |
Oaz1 |
ornithine decarboxylase antizyme 1 |
|
decreases expression |
EXP |
10 |
80,289,401 |
80,292,035 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
multiple interactions |
EXP |
6 |
113,276,970 |
113,284,182 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
increases expression |
ISO |
6 |
113,276,970 |
113,284,182 |
RGD:6480464 |
CTD |
| G |
Olfr1352 |
olfactory receptor 1352 |
|
decreases expression |
EXP |
10 |
78,443,795 |
78,447,466 |
RGD:6480464 |
CTD |
| G |
Olfr1404 |
olfactory receptor 1404 |
|
decreases expression |
EXP |
1 |
175,145,738 |
175,146,771 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
increases expression |
ISO |
15 |
83,206,037 |
83,295,036 |
RGD:6480464 |
CTD |
| G |
Pak2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
decreases expression |
ISO |
16 |
32,017,949 |
32,079,359 |
RGD:6480464 |
CTD |
| G |
Pcdh1 |
protocadherin 1 |
|
decreases expression |
ISO |
18 |
38,356,348 |
38,369,416 |
RGD:6480464 |
CTD |
| G |
Pcdhb17 |
protocadherin beta 17 |
|
increases expression |
EXP |
18 |
37,644,675 |
37,647,944 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
|
increases expression |
EXP |
2 |
172,978,574 |
172,984,755 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pdcd2 |
programmed cell death 2 |
|
increases expression |
ISO |
17 |
15,658,539 |
15,664,265 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
decreases expression |
ISO |
7 |
121,558,768 |
121,681,451 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
|
decreases expression |
ISO |
6 |
5,433,351 |
5,446,278 |
RGD:6480464 |
CTD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
increases expression |
EXP |
17 |
43,705,400 |
43,749,150 |
RGD:6480464 |
CTD |
| G |
Pld2 |
phospholipase D2 |
|
increases expression |
ISO |
11 |
70,353,666 |
70,371,612 |
RGD:6480464 |
CTD |
| G |
Pola1 |
polymerase (DNA directed), alpha 1 |
|
increases expression |
EXP |
X |
90,550,105 |
90,877,494 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
increases expression |
ISO |
7 |
51,788,114 |
51,804,185 |
RGD:6480464 |
CTD |
| G |
Pold4 |
polymerase (DNA-directed), delta 4 |
|
increases expression |
EXP |
19 |
4,231,899 |
4,233,634 |
RGD:6480464 |
CTD |
| G |
Pole2 |
polymerase (DNA directed), epsilon 2 (p59 subunit) |
|
increases expression |
EXP |
12 |
70,302,766 |
70,329,177 |
RGD:6480464 |
CTD |
| G |
Polg |
polymerase (DNA directed), gamma |
|
increases expression |
EXP |
7 |
86,594,269 |
86,611,159 |
RGD:6480464 |
CTD |
| G |
Poli |
polymerase (DNA directed), iota |
|
increases expression |
EXP |
18 |
70,668,334 |
70,689,975 |
RGD:6480464 |
CTD |
| G |
Pou3f1 |
POU domain, class 3, transcription factor 1 |
|
decreases expression |
ISO |
4 |
124,334,889 |
124,337,899 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
decreases expression |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
decreases expression |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
increases expression |
ISO |
8 |
87,493,547 |
87,498,212 |
RGD:6480464 |
CTD |
| G |
Preb |
prolactin regulatory element binding |
|
increases expression |
ISO |
5 |
31,254,040 |
31,262,734 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases expression |
ISO |
11 |
107,794,701 |
108,205,202 |
RGD:6480464 |
CTD |
| G |
Prkcg |
protein kinase C, gamma |
|
increases expression |
ISO |
7 |
3,303,658 |
3,331,005 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
increases expression |
ISO |
4 |
154,634,229 |
154,735,500 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
|
increases expression |
ISO |
14 |
66,772,094 |
66,899,889 |
RGD:6480464 |
CTD |
| G |
Rab1 |
RAB1, member RAS oncogene family |
|
increases expression |
ISO |
11 |
20,101,605 |
20,126,859 |
RGD:6480464 |
CTD |
| G |
Rab10 |
RAB10, member RAS oncogene family |
|
increases expression |
ISO |
12 |
3,247,428 |
3,309,969 |
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
increases expression |
ISO |
2 |
35,035,725 |
35,056,640 |
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
decreases expression |
ISO |
2 |
35,035,725 |
35,056,640 |
RGD:6480464 |
CTD |
| G |
Rab7 |
RAB7, member RAS oncogene family |
|
decreases expression |
ISO |
6 |
87,950,429 |
87,963,684 |
RGD:6480464 |
CTD |
| G |
Rab7 |
RAB7, member RAS oncogene family |
|
increases expression |
ISO |
6 |
87,950,429 |
87,963,684 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
increases expression |
ISO |
2 |
28,368,687 |
28,408,602 |
RGD:6480464 |
CTD |
| G |
Ramp1 |
receptor (calcitonin) activity modifying protein 1 |
|
increases expression |
ISO |
1 |
93,076,399 |
93,121,773 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
increases expression |
ISO |
5 |
129,526,031 |
129,530,196 |
RGD:6480464 |
CTD |
| G |
Reg3b |
regenerating islet-derived 3 beta |
|
decreases expression |
ISO |
6 |
78,320,879 |
78,323,460 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
decreases expression |
ISO |
18 |
10,064,399 |
10,181,790 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
increases expression |
ISO |
12 |
16,901,784 |
16,995,080 |
RGD:6480464 |
CTD |
| G |
Scn2a1 |
sodium channel, voltage-gated, type II, alpha 1 |
|
decreases expression |
ISO |
2 |
65,508,502 |
65,605,504 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
10 |
21,601,990 |
21,719,709 |
RGD:6480464 |
CTD |
| G |
Shq1 |
SHQ1 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
6 |
100,523,076 |
100,621,151 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases expression |
ISO |
15 |
100,218,329 |
100,253,486 |
RGD:6480464 |
CTD |
| G |
Slc15a4 |
solute carrier family 15, member 4 |
|
decreases expression |
ISO |
5 |
128,076,036 |
128,097,762 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
ISO |
11 |
69,755,788 |
69,761,692 |
RGD:6480464 |
CTD |
| G |
Slc35d1 |
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
|
increases expression |
ISO |
4 |
102,844,323 |
102,887,489 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
increases expression |
ISO |
6 |
91,634,061 |
91,709,057 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Spon1 |
spondin 1, (f-spondin) extracellular matrix protein |
|
decreases expression |
ISO |
7 |
120,909,512 |
121,186,889 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
6 |
86,145,245 |
86,225,443 |
RGD:6480464 |
CTD |
| G |
Tgfbr1 |
transforming growth factor, beta receptor I |
|
decreases expression |
EXP |
4 |
47,366,177 |
47,427,796 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
ISO |
9 |
115,996,813 |
116,084,481 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
decreases expression |
ISO |
6 |
125,299,741 |
125,312,501 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
EXP |
11 |
98,854,261 |
98,885,503 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases expression |
ISO |
11 |
98,854,261 |
98,885,503 |
RGD:6480464 |
CTD |
| G |
Traf3 |
TNF receptor-associated factor 3 |
|
decreases expression |
EXP |
12 |
112,404,759 |
112,505,359 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases expression |
ISO |
12 |
92,639,433 |
92,778,949 |
RGD:6480464 |
CTD |
| G |
Ttn |
titin |
|
increases expression |
EXP |
2 |
76,542,041 |
76,820,604 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
ISO |
4 |
57,956,245 |
57,969,283 |
RGD:6480464 |
CTD |
| G |
Txn2 |
thioredoxin 2 |
|
increases expression |
ISO |
15 |
77,745,481 |
77,759,424 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
increases expression |
ISO |
17 |
37,330,837 |
37,333,046 |
RGD:6480464 |
CTD |
| G |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
|
increases expression |
ISO |
3 |
135,101,723 |
135,130,142 |
RGD:6480464 |
CTD |
| G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
|
decreases expression |
EXP |
10 |
77,085,066 |
77,108,735 |
RGD:6480464 |
CTD |
| G |
Usf2 |
upstream transcription factor 2 |
|
increases expression |
ISO |
7 |
31,730,267 |
31,741,822 |
RGD:6480464 |
CTD |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
increases expression |
ISO |
9 |
43,875,104 |
43,903,710 |
RGD:6480464 |
CTD |
| G |
Usp7 |
ubiquitin specific peptidase 7 |
|
increases expression |
ISO |
16 |
8,688,815 |
8,738,435 |
RGD:6480464 |
CTD |
| G |
Uty |
ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome |
|
increases expression |
EXP |
Y |
433,587 |
582,181 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D receptor |
|
decreases expression |
ISO |
15 |
97,684,858 |
97,738,727 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
increases expression |
EXP |
8 |
55,162,886 |
55,271,808 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases expression |
ISO |
11 |
5,420,970 |
5,425,875 |
RGD:6480464 |
CTD |
| G |
Xist |
inactive X specific transcripts |
|
decreases expression |
EXP |
X |
100,655,712 |
100,678,572 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
increases expression |
ISO |
12 |
21,396,190 |
21,423,297 |
RGD:6480464 |
CTD |
Term paths to the root
|